p53R270H-dependent transcriptomic analysis and chromatin accessibility (ATAC-seq) profiling uncovered a molecular connection between p53-driven drug tolerance and epigenetic regulations in pancreatic cancer [58]. The gene discussed is TP53; the disease is familial pancreatic carcinoma.